Abvance therapeutics Headquarters & Office Locations

Abvance therapeutics (Private) is headquartered in Reno, Nevada, United States. Founded in 2016, the company operates across 1 countries with approximately 5 employees worldwide.

Where is Abvance therapeutics's main office?

Abvance therapeutics's main headquarters office is located at 38 Bennington Ct., Reno, Nevada 89511. This serves as the company's primary corporate address and is home to its executive leadership team.

Abvance therapeutics regional offices

Beyond its headquarters in Reno, Abvance therapeutics maintains 1 offices across 1 countries. Regional offices span 1 countries.

Abvance therapeutics contact information

The main switchboard for Abvance therapeutics headquarters can be reached at —. For investor relations, visit abvancetherapeutics.com/investor-relations.

What does Abvance therapeutics do?

Traditional insulin replacement therapy involves multiple daily insulin injections or the delivery of insulin by a pump, the need for careful blood glucose monitoring, and the fear of an unwanted fall in blood glucose (hypoglycemia). Fear of hypoglycemia prevents optimal glycemic management leading to long-term hyperglycemia and damage to the body (kidney, heart, extremities). Abvance is a biotechnology company developing a new insulin: glucagon formulation called ABV100 for preventing hypoglycemia. Patients who use ABV100 instead of insulin will experience improved blood glucose control with a safety buffer against hypoglycemia. In addition, ABV100 does not require new behavioral changes or devices and will lighten the daily burden of disease management. ABV100: A titratable, fixed ratio combination of two FDA-approved peptides to control glycemia while mitigating the threat of hypoglycemia.